Skip to content

Mdeon

Active
Non-profit associationfounded 2006active for 20 yearsCulliganlaan 2 D, 1831 Machelen (Brab.), Belgium46 active companies are registered at this addressKBO/BCE: BE 0882.170.755
Summary

Mdeon has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.1m and a net result of €260,551. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 95% of 1,151 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
MdeonActiveChecked score 97/100
Risk analysis ReportCompare

History

Mdeon was incorporated on 29 June 2006.1 The registered office was moved to Diegem in 2025.2 Total assets rose from €515,204 in 2018 to €2.1m in 2025 and headcount from 0.8 to 0.7 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-04-2025
  3. 3National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
23-03
Gazette deed Withdrawal: Belgische Vereniging van Artsensyndicaten (BVAS), vzw (member)
Reappointments: Belgian Association of Consumer Healthcare Industry (BACHI), Algemene Pharmaceutische Bond (APB), Koninklijke Maatschappij, Nationale Federatie van Belgische Apothekersverenigingen and 14 others · Resignations: Belgische Vereniging van Artsensyndicaten (BVAS), vzw (day-to-day manager) and Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (day-to-day manager) · Appointments: Belgische Vereniging van Artsensyndicaten (BVAS), vzw (day-to-day manager) and Medaxes, Belgische Federatie van producenten van Generische Geneesmiddelen, vzw (day-to-day manager)53 facts ▸
  • Board meeting, 16-12-2025
  • Member resignation, Belgische Vereniging van Artsensyndicaten (BVAS), vzw (member)
  • General meeting, 16-12-2025
  • Director reappointment, Belgian Association of Consumer Healthcare Industry (BACHI) (director)
  • Director reappointment, Algemene Pharmaceutische Bond (APB), Koninklijke Maatschappij, Nationale Federatie van Belgische Apothekersverenigingen (director)
  • Director reappointment, Algemene Unie van Verpleegkundigen van België (AUVB), vzw (director)
  • Director reappointment, Instituut voor Permanente Studie voor Apothekers (IPSA), vzw (director)
  • Director reappointment, Konfederatie der Belgische Geneesheren of Kartel (ASGB-GBO-SBGS/SBMS), vzw (director)
  • Director reappointment, Société Scientifique des Pharmaciens Francophones (SSPF), vzw (director)
  • Director reappointment, Syndicaat van Vlaamse Huisartsen (SVH), vzw (director)
  • Director reappointment, beMedTech, vzw (director)
  • Director reappointment, Vereniging der Coöperatieve Apotheken van België (OPHACO), Erkende Beroepsvereniging (director)
  • +41 further facts in this act
19-03
NBB filing Annual accounts filed
financial year 2025 · full format
19-03
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Liquidity more than triplescurrent ratio 822.62
Current ratio from 224.12 to 822.62; short-term debt falls from €8,136 to €2,197.
31-12
Financial Equity above €2mequity €2.1m ▲14%
5 profitable years in a row build equity to €2.1m.
08-07
NBB filing Annual accounts filed
financial year 2024 · full format
08-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
08-07
NBB filing Annual accounts filed
financial year 2023 · full format
22-04
Gazette deed Appointments: Belgian Association of Consumer Healthcare Industry (BACHI), Algemene Unie van Verpleegkundigen van België (AUVB) and 3 others
Resignations: Belgische Vereniging van Artsensyndicaten (BVAS), pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie and Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS) · Reappointments: Belgian Association of Consumer Healthcare Industry (BACHI), Algemene Pharmaceutische Bond (APB) and 13 others · Permanent representatives: Vincent Lamy, Herman Van Eeckhout and 19 others82 facts ▸
  • General meeting, 18-03-2025
  • Registered-office move, Park Lane D,Culliganlaan 2D.3,1831 Diegem
  • Director appointment, Belgian Association of Consumer Healthcare Industry (BACHI) (chair)
  • Director appointment, Algemene Unie van Verpleegkundigen van België (AUVB) (eerste ondervoorzitter)
  • Director appointment, Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS) (tweede ondervoorzitter)
  • Director resignation, Belgische Vereniging van Artsensyndicaten (BVAS) (director)
  • Director resignation, pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie (director)
  • Director resignation, Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS) (director)
  • Director appointment, Belgische Vereniging van Artsensyndicaten (BVAS) (director)
  • Director appointment, pharma.be - Algemene Vereniging van de Geneesmiddelenindustrie (director)
  • Director appointment, Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS) (director)
  • Director reappointment, Belgian Association of Consumer Healthcare Industry (BACHI) (director)
  • +70 further facts in this act
2024
16-07
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
09-07
Gazette deed Appointments: Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS), Belgian Association of Consumer Healthcare Industry (BACHI) and 6 others
Resignations: Instituut voor Permanente Studie voor Apothekers (IPSA) (director) and beMedTech (director) · Permanent representatives: Ivo Van Den Wijngaert, Marnix Denys and 18 others · Reappointments: Belgian Association of Consumer Healthcare Industry (BACHI), Algemene Pharmaceutische Bond (APB) and 12 others64 facts ▸
  • General meeting, 12-03-2024
  • Director appointment, Verbond der Belgische Beroepsverenigingen van Geneesheren-Specialisten (VBS) (chair)
  • Director appointment, Belgian Association of Consumer Healthcare Industry (BACHI) (eerste ondervoorzitter)
  • Director appointment, Algemene Unie van Verpleegkundigen van België (AUVB) (tweede ondervoorzitter)
  • Director resignation, Instituut voor Permanente Studie voor Apothekers (IPSA) (director)
  • Director resignation, beMedTech (director)
  • Permanent representative, Ivo Van Den Wijngaert
  • Permanent representative, Marnix Denys
  • Director appointment, Instituut voor Permanente Studie voor Apothekers (IPSA) (director)
  • Director appointment, beMedTech (director)
  • Director appointment, Zorgnet Icuro (director)
  • Director appointment, Vlaamse Vereniging van Ziekenhuisinstrumentatietechnici (director)
  • +52 further facts in this act
19-01
Gazette deed Amendment of the articles
General meeting1 fact ▸
  • General meeting, 18-12-2023
Show earlier events
2023
31-12
Financial Liquidity more than doubledcurrent ratio 147.59
Current ratio from 51.48 to 147.59; short-term debt falls from €26,815 to €10,832.
09-10
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 70 days late
2022
31-12
Financial Highest result from 2018 to 2025net €612,262 ▲74.2%
Operating result €642,871, net result €612,262, both a record.
31-12
Financial Equity above €1mequity €1.4m ▲80.5%
2 profitable years in a row build equity to €1.4m.
07-10
NBB filing Annual accounts filed
financial year 2021 · abbreviated format · 68 days late
2021
31-12
Financial Back to profitnet €351,465
Net result €351,465 after one loss-making year.
31-12
Financial Equity above €500,000equity €760,894 ▲85.8%
Equity rises from €409,429 to €760,894.
04-05
NBB filing Annual accounts filed
financial year 2020 · abbreviated format
2020
31-12
Financial Weakest financial yearnet -€93,242
Net result drops to -€93,242, the lowest in the series; recovery starts the following year.
27-11
NBB filing Annual accounts filed
financial year 2019 · abbreviated format · 119 days late
2019
31-12
Financial Equity above €500,000equity €502,670 ▲14.3%
A profit in every financial year since 2018 builds equity to €502,670.
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 22 annual accounts filed, the latest 10 are here; all 22 are under Financials. An act published in both Dutch and French appears here once.
8 of 44 deeds read
About the unread acts

Of the 44 Belgian Official Gazette deeds we know for this company, 8 have been read. The other 36 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure